Séroprévalence et Etude Biomoléculaire du Virus de l’Hépatite E à Brazzaville

Review Article


Abstract views: 12 / PDF downloads: 4

Authors

  • Jile Florient Mimiesse
  • Blaise Emmanuelle Daniela Mondinzoko
  • Anicet Luc Magloire Boumba
  • Jhonsial Bovane Molami
  • Bredin Rock Bissala
  • Ngala Akoa Itoua-Ngaporo
  • Stéphane Rody Ngami
  • Clausina Ahoui-Apendi
  • Arnaud Mongo-Onkouo
  • Mauria Ibobi
  • Bénédicte Ahombo
  • Hostaud Atipo Ibara
  • Jul Auriol Ata
  • Peres Mardoché Motoula Latou
  • Marlyse Ngalessami Mouakosso
  • Blaise Irénée Atipo Ibara

DOI:

https://doi.org/10.58372/2835-6276.1356

Keywords:

frequency, hepatitis E virus, Brazzaville

Abstract

Objectives: To describe the serological and biomolecular profile of hepatitis E virus (HEV) in Brazzaville.

Population and methods: This was a descriptive cross-sectional study conducted from January 1 to September 30, 2024, at blood collection centers of the National Blood Transfusion Center (CNTS) and pig farms in the city of Brazzaville. Blood donors and pig farmers aged 18 years and older, regardless of sex, who agreed to participate in the study were included. Sociodemographic characteristics, risk factors for HEV transmission, IgM, IgG, and viral RNA were the variables studied. The statistical tests used were Pearson's chi-squared test and odds ratio with adjustment. The significance level was set at 0.05.

Results: 98 people were recruited for our study. Men represented 53% and women 47%. The mean age was 39.18 ± 14.15 years, with a range of 18 to 77 years. More than half of the population had contact with animals, and in 43% of cases, this contact was with pigs. The overall frequency of HEV was 19.3% (n=19/98). The frequencies of anti-HEV IgG and IgM antibodies were 84% (n=16/19) and 16% (n=3/19), respectively. The frequency of HEV was 17.6% (n=12/68) among blood donors and 23.33% (n=7/38) among pig farmers. RNA was detectable in 26.32% of cases.

Conclusion: This study constitutes the first seroprevalence and molecular biology survey of HEV in Congo-Brazzaville. The results indicate that HEV infection is present in Brazzaville, particularly among blood donors and pig farmers, with a high seroprevalence.

References

Handra-Luca A, Tengher I, Ziol M. Aspects histopathologiques des infections à virus hépatotropes. Rev Francoph Lab. 2007 ; 2007(388) :41-8.

Ankavay M, Dubuisson J, Cocquerel L. Le virus de l’hépatite E : un virus méconnu qui se dévoile. Med Sci (Paris). 2018 ; 34(12) :1071-8.

Organisation Mondiale de la Santé. Principaux repères sur l’hépatite E [En ligne]. [Cité le 22 juin 2024]. Disponible : https://www.who.int/fr/news-room/fact-sheets/detail/hepatitis-e

Severo CA, Abensur P, Buisson Y, Lafuma A, Detournay B, Pechevis M. An outbreak of hepatitis A in a French day-care centre and efforts to combat it. Eur J Epidemiol. 1997 ; 13(2) :139-44.

Buisson Y. Hépatites A et E : épidémiologie, transmission. J. Pediatrie Pueric. 1994 ; 7(3) :165-7.

Izopet J, Kamar N. Hépatite E : de la transmission zoonotique du virus à l’évolution chronique de l’infection chez l’immunodéprimé. Med Sci (Paris). 2008 ; 24(12) :1023-5.

Bihl F, Negro F. Hépatite E : nouveaux aspects d’une vieille maladie. Rev Med Suisse. 2008 ; 169(31) :1863-6.

Y. Qu’attendons-nous pour vacciner contre l’hépatite E ? Bull. Acad. natl. Méd. 2017; 201(4):671-80.

Organisation Mondiale de la Santé 2024. Hépatite E – Tchad [En ligne]. [Cité le 25 juillet 2024]. Disponible : https://www.who.int/fr/emergencies/disease-outbreaknews/item/2024-DON517

Escribà JM, Nakoune E, Recio C, Massamba PM, Matsika-Claquin MD, Goumba C, et al. Hepatitis E, Central African Republic. Emerg Infect Dis. 2008 ; 14(4) :681-3.

Feldt T, Sarfo FS, Zoufaly A, Phillips RO, Burchard G, Van Lunzen J, et al. Hepatitis E virus infections in HIV-infected patients in Ghana and Cameroon. J. Clin .Virol. sept 2013 ; 58(1) :18-23.

Bivigou Mboumba B, Rouet F, Mouinga-Ondémé A, Deleplancque L, Sica J, Njouom R, et al. Hepatitis B, C, and E infection among HIV-infected patients in Franceville, Gabon: retrospective cross-sectional study. Med. sante trop. 2017; 27(3):274-80.

UNDP, United Nations Development Programme. Human Development Insights [En ligne]. [Cité le 25 novembre 2024]. Disponible sur : https://hdr.undp.org/datacenter/country-insights

Aamoum A, Baghdad N, Boutayeb H, Benchemsi N. Séroprévalence de l’hépatite E à Casablanca. MMI. 2004; 34(10):491-2. 16. Escribà JM, Nakoune E, Recio C, Massamba PM, Matsika-Claquin MD, Goumba C, et al. Hepatitis E, Central African Republic. Emerg Infect Dis. 2008 ; 14(4) :681-3.

Balayan MS, Fedorova O-E, Mikhailow MI, Rytick PG, Pankova GY, Eremin PO, et al.Epidemiology of hepatitis E virus infection. J viral hepat.1997 ; 4:155–65.

Erlinger S. L’infection par le virus de l’hépatite E : des hépatites par grandes épidémies. Press Med. 1997 ; 26(9) :422–3.

Teyssuo R, Van cuyck-Grandre H, Buisson Y, Hépatite E.EMC Hépatologie 1997 7-015- B-55. Mateos ML, Camarero C, Casa E, Teruel J-L, Mir N, Baquero F. HEV: prelevance in blood donors and risk groups. Vox sang. 1999; 76:78–80

Jian-Te Lee, Pei-Lan Shao, Luan-Yin Chang, Ning-Shao Xia, Pei-Jer Chen, Chun-Yi Lu, Li-Min Huang. Seroprevalence of Hepatitis E Virus Infection among Swine Farmers and the General Population in Rural Taiwan. J P One. 2013. 26 ; 8(6)

Modiyinji AF. Prévalence, diversité génétique et transmission inter-espèces du virus de l’hépatite E dans quelques regions du Cameroun. [Thèse de doctorat en ligne].Yaoundé : université de Yaoundé 1 ; 2022 [Cité le 4 octobre]. Disponible : https://dicames.online/jspui/bitstream/20.500.12177/10825/1/FS_These_BC_23_0224.pdf

Bivigou Mboumba B, Rouet F, Mouinga-Ondémé A, Deleplancque L, Sica J, Njouom R, et al. Hepatitis B, C, and E infection among HIV-infected patients in Franceville, Gabon.

Downloads

Published

2025-11-20

How to Cite

Jile Florient Mimiesse, Blaise Emmanuelle Daniela Mondinzoko, Anicet Luc Magloire Boumba, Jhonsial Bovane Molami, Bredin Rock Bissala, Ngala Akoa Itoua-Ngaporo, Stéphane Rody Ngami, Clausina Ahoui-Apendi, Arnaud Mongo-Onkouo, Mauria Ibobi, Bénédicte Ahombo, Hostaud Atipo Ibara, Jul Auriol Ata, Peres Mardoché Motoula Latou, Marlyse Ngalessami Mouakosso, & Blaise Irénée Atipo Ibara. (2025). Séroprévalence et Etude Biomoléculaire du Virus de l’Hépatite E à Brazzaville: Review Article. American Journal of Medical and Clinical Research & Reviews, 4(11), 1–7. https://doi.org/10.58372/2835-6276.1356

Issue

Section

Articles